ArticleCancer research2019

Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.

Bradley D Shields et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.